Kenneth M Jacobsohn - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Kenneth M Jacobsohn

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Cancers|October 23, 2021

Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?Paul Beinhoff, Lavannya Sabharwal, Vindhya Udhane, et al.

Cancers|September 28, 2023

T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical RecurrenceSavannah R Duenweg, Samuel A Bobholz, Michael J Barrett, et al.

Medrxiv : the Preprint Server for Health Sciences|February 6, 2026

Radio-pathomic maps of histo-morphometric features trained with whole mount prostate histology distinguish prostate cancer on MP-MRISavannah R Duenweg, Samuel A Bobholz, Allison K Lowman, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Cancers|October 23, 2021

Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?Paul Beinhoff, Lavannya Sabharwal, Vindhya Udhane, et al.

Cancers|September 28, 2023

T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical RecurrenceSavannah R Duenweg, Samuel A Bobholz, Michael J Barrett, et al.

Medrxiv : the Preprint Server for Health Sciences|February 6, 2026

Radio-pathomic maps of histo-morphometric features trained with whole mount prostate histology distinguish prostate cancer on MP-MRISavannah R Duenweg, Samuel A Bobholz, Allison K Lowman, et al.

Pageof 2